Fig. 4: Time-dependent AUROC of ENKTL-ML score and existing indexes.
From: Development and validation of a predictive model for extranodal natural killer/T-cell lymphoma
Prediction of OS in the evaluation cohort (a), external validation cohort 1 (c), external validation cohort 2 (e); Prediction of PFS in the evaluation (b), external validation cohort 1 (d); external validation cohort 2 (f). AUROC area under the receiver operating characteristic curve, OS overall survival, PFS progression-free survival.
